Neurology

Epilepsy pills recalled after patient finds ‘metallic particle’ inside

Epilepsy pills recalled after patient finds ‘metallic particle’ inside

A batch of anti-seizure medicine has been recalled as a “precautionary measure” after a patient discovered a small piece of metal inside a tablet, the pharmacy negotiator has announced.

Dismissed nine times by GP: Pharmacist ‘saves life’ of student with brain tumor

Dismissed nine times by GP: Pharmacist ‘saves life’ of student with brain tumor

A doctor told Lucy Younger that her brain tumour symptoms were from “drinking too much” and being “away from home” before an “incredible” pharmacist sent her to get an MRI scan... 

Shortage warnings: ADHD, opioid dependence and period delay drugs

Shortage warnings: ADHD, opioid dependence and period delay drugs

The pharmacy negotiator has warned that one ADHD drug is in short supply, while some period delay and opioid dependency drugs will remain “out of stock” into the autumn.  

Multiple sclerosis drug recalled over unacceptable 'variability'

Multiple sclerosis drug recalled over unacceptable 'variability'

A manufacturer has recalled a medicine used to treat multiple sclerosis (MS) “as a precautionary measure”, the pharmacy negotiator has announced.

Three HRT medicines discontinued amid ADHD drug recall

Three HRT medicines discontinued amid ADHD drug recall

Tomorrow will see three hormone replacement therapy (HRT) drugs removed from the pre-payment certificate (PPC) list, while 39 batches of an ADHD drug have been recalled.  

Adult ADHD prescriptions up 28% in England, NHS data reveals

Adult ADHD prescriptions up 28% in England, NHS data reveals

As the amount of medication prescribed for ADHD rose by nearly 15% in 2023/24, a Labour councillor has blamed Brexit for shortages of medicines to treat the condition.

Guanfacine ADHD medication ‘out of stock’ until May

Guanfacine ADHD medication ‘out of stock’ until May

The DH has announced that a medication for attention deficit hyperactivity disorder (ADHD) is out of stock until next month amid ongoing shortages of drugs to treat the condition.

Asthma drug under ‘review’ after surge in psychiatric incidents

Asthma drug under ‘review’ after surge in psychiatric incidents

The medicines watchdog is finalising a review of asthma drug montelukast after a rise in Yellow Card reports, amid a shortage of other asthma drugs. 

Medicines watchdog issues valproate warning for would-be fathers

Medicines watchdog issues valproate warning for would-be fathers

Children born to men on valproate are more likely to develop neurodevelopmental disorders, the medicines watchdog has warned.

DH and MHRA ban wholesalers from hoarding or exporting five ADHD drugs

DH and MHRA ban wholesalers from hoarding or exporting five ADHD drugs

The Department of Health and Social Care (DH) and the Medicines and Healthcare products Regulatory Agency (MHRA) have added five ADHD medications to the list of drugs that wholesalers are prevented from exporting or hoarding.